0
contact-banner

Crinecerfont

Crinecerfont

API0232752

Crinecerfont

Crinecerfont is used for congenital adrenal hyperplasia; orphan drug.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    752253-39-7

  • Synonyms

    Crinecerfont; 752253-39-7; SSR125543

  • CHEMBL ID

    CHEMBL291657

  • Indications

  • Molecule Type

    Small molecule

  • Compound CID

    5282340

  • Molecular Weight (g/mol)

    483

  • Molecular Formula

    C27H28ClFN2OS

  • InChI

    InChI=1S/C27H28ClFN2OS/c1-6-11-31(24(13-19-8-9-19)20-10-7-16(2)23(29)14-20)27-30-26(18(4)33-27)21-12-17(3)25(32-5)15-22(21)28/h1,7,10,12,14-15,19,24H,8-9,11,13H2,2-5H3/t24-/m0/s1

  • InChIKey

    IEAKXXNRGSLYTQ-DEOSSOPVSA-N

  • SMILES

    CC1=C(C=C(C=C1)[C@H](CC2CC2)N(CC#C)C3=NC(=C(S3)C)C4=C(C=C(C(=C4)C)OC)Cl)F

  • IUPAC Name

    4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine

  • Exact Mass (Da)

    482.1594906

  • Monoisotopic Mass (Da)

    482.1594906

OUR PRODUCTS

  • API0231749

    Betamethasone Acetate

    Betamethasone Acetate

    987-24-6

    Learn More
  • API0233068

    Trilaciclib dihydrochloride

    Trilaciclib dihydrochloride

    1977495-97-8

    Learn More
  • API0232506

    Maralixibat Chloride

    Maralixibat Chloride

    228113-66-4

    Learn More
  • API0233526

    Fostamatinib Disodium

    Fostamatinib Disodium

    1025687-58-4

    Learn More